Saturn V Capital Management as of Dec. 31, 2024
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 24 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Disc Medicine (IRON) | 12.6 | $32M | 509k | 63.40 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 10.7 | $27M | 199k | 137.67 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 7.3 | $19M | 346k | 54.15 | |
| Cg Oncology (CGON) | 6.7 | $17M | 593k | 28.68 | |
| Vaxcyte (PCVX) | 6.5 | $17M | 204k | 81.86 | |
| Cytokinetics Com New (CYTK) | 6.4 | $16M | 348k | 47.04 | |
| Cargo Therapeutics (CRGX) | 5.7 | $15M | 1.0M | 14.42 | |
| Celcuity (CELC) | 5.5 | $14M | 1.1M | 13.09 | |
| Syndax Pharmaceuticals (SNDX) | 5.1 | $13M | 989k | 13.22 | |
| Xenon Pharmaceuticals (XENE) | 5.0 | $13M | 323k | 39.20 | |
| Argenx Se Sponsored Adr (ARGX) | 4.8 | $12M | 20k | 615.00 | |
| Cogent Biosciences (COGT) | 4.6 | $12M | 1.5M | 7.80 | |
| Merus N V (MRUS) | 3.9 | $9.9M | 235k | 42.05 | |
| Contineum Therapeutics Cl A (CTNM) | 3.3 | $8.4M | 573k | 14.65 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.9 | $4.8M | 653k | 7.32 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $4.7M | 557k | 8.47 | |
| Inozyme Pharma (INZY) | 1.5 | $3.8M | 1.4M | 2.77 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.4 | $3.6M | 815k | 4.43 | |
| Amylyx Pharmaceuticals (AMLX) | 1.3 | $3.4M | 889k | 3.78 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.2 | $3.0M | 59k | 51.13 | |
| Silence Therapeutics Ads (SLN) | 1.1 | $2.7M | 395k | 6.88 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.0 | $2.6M | 100k | 25.70 | |
| Ocular Therapeutix (OCUL) | 0.6 | $1.6M | 192k | 8.54 | |
| Mbx Biosciences (MBX) | 0.1 | $332k | 18k | 18.43 |
